NIH Plans December Initiative to Accelerate Cancer Vaccine Development
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
👇👇👇
@kill-bait.bsky.social
@kill-bait.bsky.socialNIH Plans December Initiative to Accelerate Cancer Vaccine Development
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
👇👇👇
@sigtrans-sttt.bsky.social#TumorHeterogeneity challenges antigen-specific #Vaccination.
This review explores how in situ #CancerVaccines combine immunogenic cell death, advanced delivery, microenvironment modulation, and checkpoint blockade to broaden antitumor immunity.
#STTT #OpenAccess: doi.org/10.1038/s413...
@sigtrans-sttt.bsky.socialHow can next-generation personalized #CancerVaccines overcome #Immunosuppressive microenvironments?
This review evaluates mRNA, DNA, and #Nanovaccine platforms combined with checkpoint inhibitors for durable immunity.
@uwcvi.bsky.socialThank you, In Concert for Cancer, for bringing the community together in support of our cancer vaccine research. We are grateful for your partnership and commitment to advancing research toward a cancer-free future.
@uwcvi.bsky.socialDr. Nora Disis, CVI Director, is a lead author of a new review article published by @jama.com.
The review explores the science behind cancer vaccines and the field’s shifting focus toward preventive approaches.
Read more: www.uwcvi.org/post/dr-disi...